Cargando…
Identification of Phthalates in Medications and Dietary Supplement Formulations in the United States and Canada
Background: In animal studies, some ortho-phthalates, including di(2-ethylhexyl) phthalate (DEHP) and di-n-butyl phthalate (DBP), have been shown to be reproductive and developmental toxicants. Human studies show widespread population exposure to background levels of phthalates. Limited evidence sug...
Autores principales: | Kelley, Katherine E., Hernández-Díaz, Sonia, Chaplin, Erica L., Hauser, Russ, Mitchell, Allen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Institute of Environmental Health Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295354/ https://www.ncbi.nlm.nih.gov/pubmed/22169271 http://dx.doi.org/10.1289/ehp.1103998 |
Ejemplares similares
-
“Phthalates”: Kelley et al. Respond
por: Kelley, Katherine E., et al.
Publicado: (2012) -
Medications as a Potential Source of Exposure to Phthalates in the U.S. Population
por: Hernández-Díaz, Sonia, et al.
Publicado: (2009) -
Changing Trends in Phthalate Exposures
por: Lioy, Paul J., et al.
Publicado: (2014) -
Use of Di(2-ethylhexyl) Phthalate–Containing Medical Products and Urinary Levels of Mono(2-ethylhexyl) Phthalate in Neonatal Intensive Care Unit Infants
por: Green, Ronald, et al.
Publicado: (2005) -
Medications as a source of human exposure to phthalates.
por: Hauser, Russ, et al.
Publicado: (2004)